News

MEDIA contact

press@zapprx.com

617.844.0989

 
Press Releases

ZappRx raises $25 million in Series B funding led by Qiming US Healthcare Fund with Participation from SR One and GV

Digital health company ZappRx will use the funding to build its team, drive provider adoption nationwide, and accelerate company growth

Read More

ZappRx announces new prior authorization partnership with PARx Solutions

ZappRx (zapprx.com), a digital specialty prescribing platform focused on increasing patient access to specialty therapy, announced a partnership with PARx Solutions (parxsolutions.com), a leader in helping prescribers manage prescription prior authorizations (PA). This strategic partnership combines ZappRx’s expertise in automating the specialty drug prescribing process with PARx’s expertise in helping prescribers overcome challenges experienced during prior authorization that lead to delays in patients receiving their medications.

Read More

ZappRx CEO Zoë Barry named to LinkedIn's Next Wave Top Professionals Under 35

The process of filling a prescription for a specialty drug can be incredibly time consuming and complex, requiring reams of paperwork from healthcare providers. Zoe Barry, a 31-year-old Wall Street veteran, became interested in tackling those inefficiencies after her younger brother was diagnosed with severe epilepsy.

Read More

ZappRx appoints Peter Wirth Executive Chairman

ZappRx (zapprx.com), a digital specialty prescribing platform focused on increasing patient access to therapy, today announced the appointment of Peter Wirth as Executive Chairman.

Read More

ZappRx Hires Biopharmaceutical Industry Leader as Chief Operating Officer

Boston, MA, September 20, 2016 – ZappRx (zapprx.com), a digital specialty prescribing platform focused on increasing patient access to therapy, today announced the hiring of Sandy DiCesare as Chief Operating Officer. DiCesare most recently served as VP of Commercial Operations at Takeda Oncology. She joined Millennium Pharmaceuticals in 1998 as VP, Information Technology and then served as VP, Launch Platform in 2002, leading the build-out of capabilities to support Millennium's first oncology launch. Millennium Pharmaceutical was acquired by Takeda Pharmaceutical Company Limited in 2008.

Read More

ZappRx Hires Industry Leader to Drive Commercial Growth

Boston, MA, April 27, 2016 – ZappRx (zapprx.com), a digital specialty prescribing platform focused on increasing efficient patient access to therapy, today announced the hiring of Lorrie Carr as Chief Commercial Officer. Carr previously served as Divisional VP, Enterprise Specialty Sales & Product Management at Walgreens and has held leadership roles in Global Market Access, Sales and Marketing within pharmaceutical companies Millennium Pharmaceuticals (now Takeda Oncology) and Schering-Plough (now Merck).

Read More

ZappRx helps Wonderland BookSavers donate books to Tufts Medical Center

Boston, MA, December 14, 2015 – Books are gifts that keep on giving. They inspire lifelong learning, and help improve literacy and language skills. That’s why on Tuesday, December 8, 2015, ZappRx employees partnered with Wonderland BookSavers of Connecticut and Reach Out and Read to donate nearly 2,000 books to Floating Hospital for Children at Tufts Medical Center.

Read More

ZappRx Founder and CEO Zoë Barry named to BBJ's 40 Under 40 list

Cambridge, MA, September 9, 2015 – Zoë Barry, Founder and CEO of ZappRx, the leading mobile platform that automates specialty drug prescription management for patients, physicians and pharmacists, has been named to Boston Business Journal’s prestigious 40 under 40 list. This year’s list focuses on business and civic leaders who are making a major impact in the community while also improving the civic health of the Boston area through volunteer work and other forms of philanthropy.

Read More

ZappRx raises $5.6M to bring on key talent and accelerate company growth

Boston, MA, April 2, 2015 – ZappRx (zapprx.com), today announced that it has raised a $5.6M Series A round led by SR One, the venture arm of GlaxoSmithKline, with participation from Atlas Ventures. ZappRx is building the leading mobile platform to automate specialty drug prescription management for patients, physicians, and pharmacists. The company also announced a partnership with biopharmaceutical company Zafgen (NASDAQ: ZFGN), to help automate the prescription management process for patients affected by Prader-Willi syndrome (PWS) and hypothalamic injury-associated obesity (HIAO). Additionally, Jeremy Levin, former CEO of Teva Pharmaceutical, has also joined the board of ZappRx.

Read More
Show more
 
ZappRx In the News

ZappRx Gets $1M From Atlas, SR One to E-Prescribe Specialty Meds

Xconomy Boston — Getting specialty medications can be a big hassle. Dozens of pages of forms are required. Patients rely on call centers to find out the status of their prescriptions, and can go days wondering exactly when the next refill is coming. What if you could handle it all, instead, with just a few clicks on a smartphone app?
Read More

ZappRx launches pilot test in New York, hoping to streamline the process of getting a prescription

Can a smartphone app eliminate some of the snafus that can happen in getting prescriptions from a doctor's office to a pharmacy and then into a patient's hands?
Read More

13 key seed deals of the year in Boston tech

For a sense of what the next wave of hot startups in Boston could look like, here are 13 of the local seed funding deals that caught our eye this year.
Read More

The Daily Startup: Insight VP Backs Tag-Management Co. Ensighten

In this morning’s Web roundup, Ensighten Inc. raises $40 million to advance its digital marketing technology. Opower adds a senior manager as it staffs up on utility expertise. Also, VC confidence climbs.
Read More

ZappRx Lands $1M To Rethink Prescription Processing With A Pharmacy-Agnostic Mobile Checkout Platform

Today, technology is in the process of transforming healthcare. The whole nine years: From software, medicine and insurance to fitness, care delivery and the very science behind all of it. By now, this probably sounds like a familiar refrain, and for good reason. Whether it’s the adoption of EMRs, Quantified Self-inspired wearable tech, social health communities or new digital medicines like Proteus’ FDA-approved ingestible sensors and “smart pills,” change is coming fast.
Read More

Industry To Watch In 2014: Healthcare Tech

Healthcare is miles behind the curve when it comes to technological innovation, an industry that historically has not been easy to innovate for. This month's implementation of Obamacare, however, is just one of several macro trends in the space that could well create “the perfect storm” for entrepreneurship, positioning healthcare tech as a very interesting industry to watch in 2014.
Read More
Show more